Assignee
CANJI INC
US·35 granted patents·50 pending applications·1,078 citations·filing 1992–2023
Top patents by PatentIndex Score
85 records- 0196US5837520AMethod of purification of viral vectorsCANJI INC·Filed 1995·Granted Nov 17, 1998·170 cites·27 claims
- 0294US5932210ARecombinant adenoviral vector and methods of useCANJI INC·Filed 1997·Granted Aug 3, 1999·151 cites·19 claims
- 0391US6210939B1Recombinant adenoviral vector and methods of useCANJI INC·Filed 1994·Granted Apr 3, 2001·71 cites·25 claims
- 0489US6165779ACompositions and methods for therapeutic useCANJI INC·Filed 1997·Granted Dec 26, 2000·70 cites·9 claims
- 0588US7157079B2Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2004·Granted Jan 2, 2007·32 cites·19 claims
- 0688US6635476B1Targeted vectorsCANJI INC·Filed 2000·Granted Oct 21, 2003·22 cites·26 claims
- 0786US5789244ACompositions and methods for the treatment of cancer using recombinant viral vector delivery systemsCANJI INC·Filed 1996·Granted Aug 4, 1998·70 cites·6 claims
- 0884US7462351B2Nucleic acid deliveryCANJI INC·Filed 2006·Granted Dec 9, 2008·3 cites·26 claims
- 0984US7001770B1Calpain inhibitors and their applicationsCANJI INC·Filed 1999·Granted Feb 21, 2006·78 cites·19 claims
- 1084US2024000968A1Mesothelioma Gene TherapyCANJI INC·Filed 2023·Application pending·0 cites
- 1183US6475481B2Purging of stem cell productsCANJI INC·Filed 1998·Granted Nov 5, 2002·69 cites·52 claims
- 1282US7534769B2Compositions and methods for enhancing delivery of therapeutic agents to cellsCANJI INC·Filed 2002·Granted May 19, 2009·12 cites·67 claims
- 1382US6949379B2Aptamer-mediated regulation of gene expressionCANJI INC·Filed 2001·Granted Sep 27, 2005·34 cites·28 claims
- 1477US8022044B2Compositions and methods for therapeutic useCANJI INC·Filed 2009·Granted Sep 20, 2011·2 cites·21 claims
- 1577US6989268B2Recombinant adenoviral vector and methods of useCANJI INC·Filed 2003·Granted Jan 24, 2006·5 cites·9 claims
- 1677US6312681B1Compositions and methods for the treatment of cancer using recombinant viral vector delivery systemsCANJI INC·Filed 1997·Granted Nov 6, 2001·30 cites·16 claims
- 1776US7691822B2Methods and compositions for treatment of interferon-resistant tumorsCANJI INC·Filed 2004·Granted Apr 6, 2010·6 cites·2 claims
- 1874US7851218B2Cell lines for production of replication-defective adenovirusCANJI INC·Filed 2005·Granted Dec 14, 2010·3 cites·2 claims
- 1974US6464976B1Methods and compositions for reducing immune responseCANJI INC·Filed 2000·Granted Oct 15, 2002·7 cites·4 claims
- 2074US2021322572A1Methods and compositions for treatment of interferon-resistant tumorsCANJI INC·Filed 2021·Application pending·0 cites
- 2173US7355056B2Transfection agentsCANJI INC·Filed 2004·Granted Apr 8, 2008·10 cites·72 claims
- 2273US6489305B1Methods and compositions for the treatment of ocular diseasesCANJI INC·Filed 1998·Granted Dec 3, 2002·32 cites·25 claims
- 2372US7691370B2Selectivity replicating viral vectorCANJI INC·Filed 2002·Granted Apr 6, 2010·2 cites·16 claims
- 2472US6248514B1Methods for measuring viral infectivityCANJI INC·Filed 1998·Granted Jun 19, 2001·53 cites·28 claims
- 2572US2007253932A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2007·Application pending·0 cites
- 2672US2008194002A1Compositions comprising viruses and methods for concentrating virus preparationsCANJI INC·Filed 2008·Application pending·0 cites
- 2771US2007128166A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 2871US2020164091A1Mesothelioma Gene TherapyCANJI INC·Filed 2020·Application pending·0 cites
- 2970US7157261B2Rat secreted embryonic alkaline phosphataseCANJI INC·Filed 2004·Granted Jan 2, 2007·3 cites·42 claims
- 3070US6392069B2Compositions for enhancing delivery of nucleic acids to cellsCANJI INC·Filed 1998·Granted May 21, 2002·28 cites·5 claims
- 3170US6348352B1Methods for selectively transducing pathologic mammalian cells using a tumor suppressor geneCANJI INC·Filed 1993·Granted Feb 19, 2002·20 cites·3 claims
- 3270US5994134AViral production processCANJI INC·Filed 1998·Granted Nov 30, 1999·33 cites·17 claims
- 3368US7465442B2Reduction of dermal scarringCANJI INC·Filed 2004·Granted Dec 16, 2008·3 cites·7 claims
- 3468US6649158B1Methods and compositions to induce antitumor responseCANJI INC·Filed 1999·Granted Nov 18, 2003·25 cites·5 claims
- 3568US2009148508A1Methods of compositions for the treatment of ocular diseasesCANJI INC·Filed 2008·Application pending·0 cites
- 3667US2006039893A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3767US2009048148A1Compositions and methods for therapeutic useCANJI INC·Filed 2008·Application pending·0 cites
- 3866US2008286247A1Method for selectively transducing pathologic mammalian cells using a tumor suppressor geneCANJI INC·Filed 2007·Application pending·0 cites
- 3965US2004266006A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2004·Application pending·0 cites
- 4065US2019374654A1Methods and Compositions for Treatment of Interferon-Resistant TumorsCANJI INC·Filed 2018·Application pending·0 cites
- 4165US2006099187A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 4265US2007244064A1Methods and compositions to induce antitumor responseCANJI INC·Filed 2006·Application pending·0 cites
- 4364US2009082289A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2007·Application pending·0 cites
- 4464US2008299083A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2007·Application pending·0 cites
- 4564US2007009486A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 4664US2009088398A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2008·Application pending·0 cites
- 4764US2008286239A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2008·Application pending·0 cites
- 4864US2007122379A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2006·Application pending·0 cites
- 4963US2008182807A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 5063US2004087027A1Recombinant adenoviral vector and methods of useCANJI INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 85 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →